At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 14 enrolled
Drug / intervention
Baclofen +1 moredrug
Likely dose
Baclofen 10mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study on the Biobehavioral Mechanisms of Baclofen and Alcohol Drinking
In Brief
A Phase 2 clinical trial evaluating Baclofen and Cyproheptadine for Alcoholism. Completed, enrolled 14 participants across 1 site.
Detailed Summary
This pilot trial has the goal to demonstrate the feasibility of a study to test the effects of baclofen in a laboratory experiment using cue-reactivity and alcohol-self administration paradigms in non-treatment seeking alcohol-dependent subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcoholism
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2009
First PostedFeb 2010
Primary CompletionApr 2010
Study CompletionMay 2010
TodayJul 2026
First PostedFeb 26, 2010
Enrollment StartDec 1, 2009
Primary CompletionApr 1, 2010
Study CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 16.3 years ago
Interventions
Baclofendrug
Baclofen 10mg t.i.d.
Cyproheptadinedrug
'active' placebo